Production (Stage)
NeuroPace, Inc.
NPCE
$17.68
-$0.19-1.06%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.93% | 1.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.93% | 1.93% | |||
| Cost of Revenue | -1.82% | -6.42% | |||
| Gross Profit | 7.13% | 4.98% | |||
| SG&A Expenses | 9.12% | -0.85% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.16% | -0.73% | |||
| Operating Income | -40.90% | 13.91% | |||
| Income Before Tax | -25.50% | 3.71% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -25.50% | 3.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -25.50% | 3.71% | |||
| EBIT | -40.90% | 13.91% | |||
| EBITDA | -41.41% | 13.90% | |||
| EPS Basic | -19.26% | 5.24% | |||
| Normalized Basic EPS | -14.24% | 1.04% | |||
| EPS Diluted | -19.26% | 5.24% | |||
| Normalized Diluted EPS | -14.24% | 1.04% | |||
| Average Basic Shares Outstanding | 5.24% | 1.60% | |||
| Average Diluted Shares Outstanding | 5.24% | 1.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||